Canada invests nearly $200M to help Ontario facility produce mRNA vaccines

Prime Minister Justin Trudeau announced Tuesday that the Canadian government would invest $199.16 million to help Ontario's Resilience Biotechnologies Inc. increase its manufacturing of a number of vaccines and therapeutics, including those using mRNA technology.